Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.61%
#2 Ocean Protocol Ocean Protocol +17.66%
#3 KUB Coin KUB Coin +15.01%
#4 Audiera Audiera +13.60%
#5 Perle Perle +11.14%
#6 Wiki Cat Wiki Cat +9.89%
#7 Geodnet Geodnet +8.95%
#8 Arowana Arowana +8.57%
#9 DexNet DexNet +7.78%
#10 OpenEden OpenEden +7.74%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
China Regenerative Medicine International Limited China Regenerative Medicine International Limited

China Regenerative Medicine International Limited

8158
Clasificación en acciones #32818
China Regenerative Medicine International Limited operates as an investment... China Regenerative Medicine International Limited operates as an investment holding entity, focusing on the development and distribution of a diverse portfolio of healthcare products and associated services. The company provides extensive health management solutions, covering health condition assessments, detoxification programs, fostering internal bodily balance, nourishing vital organs, and enhancing the immune system. Additionally, its beauty offerings encompass non-surgical medical aesthetics, essential dermatological care, anti-aging skin remedies, hair revitalization, skin firming treatments, localized body contouring, and intimate restoration services. Established in 1995, the organization was previously known as China Bio-Med Regeneration Technology Limited until its rebranding to China Regenerative Medicine International Limited in March 2015. Its headquarters are situated in Tsim Sha Tsui, Hong Kong.
Precio por acción
$0.02967889
Capitalización bursátil
$9.03M
Cambio (1 día)
0.00%
Cambio (1 año)
-74.21%
País
HK
Comercio China Regenerative Medicine International Limited (8158)

Categoría

Healthcare
Ganancias de China Regenerative Medicine International Limited (8158)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di China Regenerative Medicine International Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de China Regenerative Medicine International Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR